Skip to product information
1 of 1

Mastocytosis Control Test (MCT)

Mastocytosis Control Test (MCT)

Regular price €0,00 EUR
Regular price Sale price €0,00 EUR
Sale Sold out
+ 19% tax where applicable.
View full details


The Mastocytosis Control Test (MCT) is an easy-to-use disease-specific tool to assess disease control in patients with cutaneous or indolent systemic mastocytosis. The MCT is a retrospective tool and can be used directly, quickly, and easily during patient presentation. A cut off value helps distinguish patients with poorly controlled disease from patients with well-controlled disease.
MCT was developed at Charité by a team led by PD Dr. Frank Siebenhaar, PD Dr. Karsten Weller and Prof. Dr. Marcus Maurer. MCT is as of yet available for the use in Germany (German) and the USA (English). 

Quick Facts MCT:
Number of items: 5
Suited for: All adult (≥18 years) patients with cutaneous or indolent systemic mastocytosis
Recall period: retrospectively 14 days
Domains: Skin, GI tract, other symptoms
Scoring: Total Score (0-20), Cut off: 13 (≥13 corresponds to well controlled disease), scoring template available
Copyright: Moxie GmbH (
Terms of use: Free for routine clinical use and non-commercial research, fee requested for use in clinical trials/commercial research.

coming soon

Commercial or non-commercial

If you are interested or on request, we will be happy to send you our PROMs (Patient Reported Outcomes Measures) on the various topics by e-mail. 

Please understand that we have to charge a fee of 15 Euro per PRO when using our PROMs for commercial purposes. Commercial use include, for example, use in industry-sponsored studies, market research and similar purposes.

By non-commercial use we mean e.g. use for consultation hours in hospitals and private practices, use within scientific studies without sponsoring. The prerequisite is that no commercial interest is pursued.

Frequently Asked Questions

Why are there PRO (Patient Reported Outcomes) products that cost nothing and others that cost 15 Euros?

If you plan to use PRO (Patient Reported Outcomes) products (e.g. AAS, AE-QoL, UCT) commercially, there is a small fee per patient (15 €). This applies, for example, to industry-sponsored trials and clinical studies or market research.
You can order free versions, if you plan to use them for non commercial purposes, e.g. for patient management or for academia-driven non commercial
research projects. When you order PRO (Patient Reported Outcomes) products, these instruments are sent per e-mail.

I would like to use PRO (Patient Reported Outcomes) products commercially. Do I have to buy one version each for every time I plan to use it, even in the same patient?

No. Each PRO (Patient Reported Outcomes) products you purchase can be used multiple time by the same patient.

What do I do if PRO (Patient Reported Outcomes) products are not available for my country or in the language I need?

The version you are looking for is probably already under development. Feel free to get in touch with us by e-mail to check when it will be available.